Serotonin 5-HT1 Receptor Agonists
DBCAT000734Pharmacologic class
Endogenous compounds and drugs that specifically stimulate SEROTONIN 5-HT1 RECEPTORS. Included under this heading are agonists for one or more of the specific 5-HT1 receptor subtypes. A DrugBank category of 27 drugs. 20 of them are approved.
- Part of
- Serotonin Receptor Agonists
- Also known as
- 5 HT1 Agonist · 5 HT1 Agonists · 5 HT1A Agonist · 5 HT1B Agonist · 5 HT1B D Agonist
- Drugs
- 5-methoxy-N,N-dimethyltryptamine
- Almotriptan
- Aripiprazole
- Befiradol
- Brexpiprazole
- Cabergoline
- Cannabidiol
- Cariprazine
- Cinitapride
- Dihydroergotamine
- Eletriptan
- Ergotamine
- F-15599
- Flibanserin
- Frovatriptan
- Lisuride
- Naluzotan
- Naratriptan
- Piclozotan
- Rizatriptan
- Rotigotine
- Sumatriptan
- Tetrahydrocannabivarin
- Vilazodone
- Vortioxetine
What you can answer from here — as of August 12, 2019
Which targets do Serotonin 5-HT1 Receptor Agonists share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account